Enesi Pharma hits milestone in thermostable solid-dose live vaccines development

Enesi has achieved a key milestone in development of thermostable solid-dose live vaccines against measles and rubella

picture of

Breaking News

Protagen Protein Services merges with GeneWerk

The move establishes a premier, protein and gene analytic testing service platform worldwide

Repligen plans Polymem acquisition to expand hollow fibre capabilities

The CDMO has made the acquisition to significantly expands hollow fibre membrane and module production capabilities for ...

Thermo Fisher launches next-gen mass spectrometry solutions at summit

The new systems and software tools support scientists working across a wide range of applications, from proteomics ...

Decentralised manufacturing: how outsourcing is helping to bring the personalised medicine promise to reality

Personalised medicine represents a revolution in healthcare strategies. Combining traditional clinical information with ...

Avantor acquires RIM Bio to expand single-use business into China

Avantor has acquired a China-based manufacturer of single-use bioprocess bags and assemblies for biopharmaceutical ...

Cell-based therapy specialist Solentim expands European operations

The England-based company has established a new EU entity based in Ireland to facilitate frictionless business within ...

Using ddPCR to accurately quantify AAV viral titre and integrity

Gene therapy is primed to become the next major development in medicine and bring relief to patients living with ...

Catalent acquires third facility in Belgium for pDNA manufacturing

CDMO Catalent has acquired liver disease specialist Promethera's cell therapy manufacturing subsidiary, including its ...

German CDMO to spend $84m expanding biological cGMP space

Richter-Helm BioLogics has received investment for the new multi-product biological manufacturing facility that is ...

Oncolytic viruses: the key to advancing novel therapies to market

As researchers continue to uncover and understand the enormous complexities of cancer, emerging technology and novel ...

Opportunities to scale AAV viral vector production for gene therapies

Gene therapies hold tremendous potential as a treatment modality for inherited human diseases. This emerging ...

Bispecific antibodies: an exciting new class of emerging therapeutics

Since 2015, when the first bispecific received US FDA approval, these game-changing antibodies have rocketed in ...

Enesi Pharma hits milestone in thermostable solid-dose live vaccines development

Enesi has achieved a key milestone in development of thermostable solid-dose live vaccines against measles and rubella

Thermo Fisher launches first cleanroom-compatible CO2 incubator for cell culture

Thermo Fisher has designed the cell growth incubator with in-chamber HEPA filtration, on-demand 180°C sterilisation ...